Ontogeny of the facial phenotypic variability in Mexican patients with 22q11.2 deletion syndrome

被引:5
|
作者
Farrera, Arodi [1 ]
Villanueva, Maria [1 ]
Vizcaino, Alfredo [2 ]
Medina-Bravo, Patricia [3 ]
Balderrabano-Saucedo, Norma [4 ]
Rives, Mariana [5 ]
Cruz, David [5 ]
Hernandez-Carbajal, Elizabeth [2 ,6 ]
Granados-Riveron, Javier [7 ]
Sanchez-Urbina, Rocio [6 ,8 ]
机构
[1] UNAM, Inst Invest Antropol, Ciudad De Mexico, Mexico
[2] Hosp Infantil Mexico Dr Federico Gomez, Dept Cardiol, Ciudad De Mexico, Mexico
[3] Hosp Infantil Mexico Dr Federico Gomez, Dept Endocrinol, Ciudad De Mexico, Mexico
[4] Hosp Infantil Mexico Dr Federico Gomez, Lab Invest Cardiopatias Congenitas, Ciudad De Mexico, Mexico
[5] Inst Nacl Cardiol Dr Ignacio Chavez, Lab Genom, Ciudad De Mexico, Mexico
[6] Inst Politecn Nacl, Escuela Super Med, Ciudad De Mexico, Mexico
[7] Hosp Infantil Mexico Dr Federico Gomez, Lab Invest Genom Genet & Bioinformat, Ciudad De Mexico, Mexico
[8] Hosp Infantil Mexico Dr Federico Gomez, Lab Invest Biol Desarrollo & Teratogenesis Expt, Dr Marquez 162 Col Doctores, Delegacion Cuauhtemoc 06720, DF, Mexico
关键词
22q11.2; Ontogeny; Facial features; Allometry; AFRICAN-AMERICAN PATIENTS; CONGENITAL HEART-DEFECTS; CLINICAL-FEATURES; VELOCARDIOFACIAL SYNDROME; MICRODELETION SYNDROME; DIGEORGE-SYNDROME; GROWTH-HORMONE; INDIVIDUALS; SHAPE; PREVALENCE;
D O I
10.1186/s13005-019-0213-9
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Background: 22q11.2 deletion syndrome is a medical condition that results from genomic loss at chromosome 22. Affected patients exhibit large variability that ranges from a severe condition to mild symptoms. In addition, the spectrum of clinical features differs among populations and even within family members. The facial features related to this syndrome are not an exception, and although part of its variation arises through development, few studies address this topic in order to understand the intra and inter-population heterogeneities. Here, we analyze the ontogenetic dynamics of facial morphology of Mexican patients with del22q11.2 syndrome. Methods: Frontal facial photographs of 37 patients (mean age = 7.65 +/- 4.21 SE) with del22q11.2DS and 200 control subjects (mean age = 7.69 +/- 4.26 SE) were analyzed using geometric morphometric methods. Overall mean shape and size differences between patients and controls were analyzed, as well as differences in ontogenetic trajectories (i.e. development, growth, and allometry). Results: We found that Mexican patients show typical traits that have been reported for the Caucasian population. Additionally, there were significant differences between groups in the facial shape and size when all the ontogenetic stages were considered together and, along ontogeny. The developmental and allometric trajectories of patients and controls were similar, but they differed in allometric scaling. Finally, patients and controls showed different growth trajectories. Conclusion: The results suggest that the typical face of patients with del22q11.2DS is established prenatally; nonetheless, the postnatal ontogeny could influence the dysmorphology and its variability through size-related changes.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] HYPERPROLINEMIA AND PSYCHIATRY IN 22Q11.2 DELETION SYNDROME
    van Asbeck, E.
    Morava-Kozicz, E.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2014, 62 (02) : 454 - 454
  • [42] Immunological aspects of 22q11.2 deletion syndrome
    A. R. Gennery
    Cellular and Molecular Life Sciences, 2012, 69 : 17 - 27
  • [43] Complement Activation in 22q11.2 Deletion Syndrome
    Dina Grinde
    Torstein Øverland
    Kari Lima
    Camilla Schjalm
    Tom Eirik Mollnes
    Tore G. Abrahamsen
    Journal of Clinical Immunology, 2020, 40 : 515 - 523
  • [44] Neuroradiographic findings in 22q11.2 deletion syndrome
    Bohm, Lauren A.
    Zhou, Tom C.
    Mingo, Tyler J.
    Dugan, Sarah L.
    Patterson, Richard J.
    Sidman, James D.
    Roby, Brianne B.
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2017, 173 (08) : 2158 - 2165
  • [45] Heterotopia in Individuals with 22q11.2 Deletion Syndrome
    Neuhaus, E.
    Hattingen, E.
    Breuer, S.
    Steidl, E.
    Polomac, N.
    Rosenow, F.
    Rueber, T.
    Herrmann, E.
    Ecker, C.
    Kushan, L.
    Lin, A.
    Vajdi, A.
    Bearden, C. E.
    Jurcoane, A.
    AMERICAN JOURNAL OF NEURORADIOLOGY, 2021, 42 (11) : 2070 - 2076
  • [46] Immunologic defects in 22q11.2 deletion syndrome
    McLean-Tooke, Andrew
    Barge, Dawn
    Spickett, Gavin P.
    Gennery, Andrew R.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 122 (02) : 362 - 367
  • [47] Neurological manifestation of 22q11.2 deletion syndrome
    Bayat, Michael
    Bayat, Allan
    NEUROLOGICAL SCIENCES, 2022, 43 (03) : 1695 - 1700
  • [48] Obesity in adults with 22q11.2 deletion syndrome
    Voll, Sarah L.
    Boot, Erik
    Butcher, Nancy J.
    Cooper, Samantha
    Heung, Tracy
    Chow, Eva W. C.
    Silversides, Candice K.
    Bassett, Anne S.
    GENETICS IN MEDICINE, 2017, 19 (02) : 204 - 208
  • [49] IMMUNE CTYOPENIAS IN 22Q11.2 DELETION SYNDROME
    Zobi, Mohamed
    Awajneh, Mohamad
    Talati, Ravi
    Lesmana, Harry
    PEDIATRIC BLOOD & CANCER, 2023, 70 : S149 - S150
  • [50] Immunological aspects of 22q11.2 deletion syndrome
    Gennery, A. R.
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2012, 69 (01) : 17 - 27